• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

Bristol-Myers Squibb Company BMY

Last Price$75.76Day Change (%)0.92%
Open Price$75.20Day Change ($)0.69
Day Range75.01–75.8752-Week Range51.82–77.12

As of Wed 7/27/2016 12:31:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation

    Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation

  2. Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals

    Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals

  3. UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

    UPDATE: Bull trend intact, S&P 500 stages garden-variety pullback

  4. Business Watch -- WSJ

    Business Watch -- WSJ

  5. MOLOGEN AG: First patient recruited in combination study with lefitolimod and Yervoy®

    MOLOGEN AG: First patient recruited in combination study with lefitolimod and Yervoy®

  6. T-cell Immunotherapy: Clinical Trial Tracker - Research Institutions Have Critical Role in Development of Novel CAR-Ts, TCRs & TILs - Research and Markets

    T-cell Immunotherapy: Clinical Trial Tracker - Research Institutions Have Critical Role in Development of Novel CAR-Ts, TCRs & TILs - Research and Markets

  7. Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

    Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

  8. Immuno-Oncology Deal Trends 2011-15 - Research and Markets

    Immuno-Oncology Deal Trends 2011-15 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.